Cargando…
AurkA controls self-renewal of breast cancer-initiating cells promoting wnt3a stabilization through suppression of miR-128
AurkA overexpression was previously found in breast cancer and associated to its ability in controlling chromosome segregation during mitosis, however whether it may affect breast cancer cells, endorsed with stem properties (BCICs), is still unclear. Surprisingly, a strong correlation between AurkA...
Autores principales: | Eterno, V., Zambelli, A., Villani, L., Tuscano, A., Manera, S., Spitaleri, A., Pavesi, L., Amato, A. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4920028/ https://www.ncbi.nlm.nih.gov/pubmed/27341528 http://dx.doi.org/10.1038/srep28436 |
Ejemplares similares
-
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
por: Caputo, Emilia, et al.
Publicado: (2015) -
AurkA nuclear localization is promoted by TPX2 and counteracted by protein degradation
por: Asteriti, Italia Anna, et al.
Publicado: (2023) -
AurkA inhibitors enhance the effects of B-RAF and MEK inhibitors in melanoma treatment
por: Caputo, Emilia, et al.
Publicado: (2014) -
Adipose-derived mesenchymal stem cells (ASCs) may favour breast cancer recurrence via HGF/c-Met signaling
por: Eterno, Vincenzo, et al.
Publicado: (2013) -
Novel FLT3/AURK multikinase inhibitor is efficacious against sorafenib-refractory and sorafenib-resistant hepatocellular carcinoma
por: Lai, You-Liang, et al.
Publicado: (2022)